Carmine Cuda

Array ( [id] => 7196768 [patent_doc_number] => 20050164377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Base material for culturing embryo stem cells and culture method' [patent_app_type] => utility [patent_app_number] => 10/494057 [patent_app_country] => US [patent_app_date] => 2002-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10778 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164377.pdf [firstpage_image] =>[orig_patent_app_number] => 10494057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851499 [patent_doc_number] => 20030143702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Vesicular monoamine transporter gene therapy in parkinson\'s disease' [patent_app_type] => new [patent_app_number] => 10/285308 [patent_app_country] => US [patent_app_date] => 2002-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27279 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143702.pdf [firstpage_image] =>[orig_patent_app_number] => 10285308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869473 [patent_doc_number] => 20030082162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'rAAV compositions for gene therapy' [patent_app_type] => new [patent_app_number] => 10/267117 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 7922 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082162.pdf [firstpage_image] =>[orig_patent_app_number] => 10267117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761307 [patent_doc_number] => 20030124669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use' [patent_app_type] => new [patent_app_number] => 10/265345 [patent_app_country] => US [patent_app_date] => 2002-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14281 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124669.pdf [firstpage_image] =>[orig_patent_app_number] => 10265345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6850993 [patent_doc_number] => 20030143196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Canine IL-13 nucleic acid molecules and uses thereof' [patent_app_type] => new [patent_app_number] => 10/262439 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52394 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 417 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143196.pdf [firstpage_image] =>[orig_patent_app_number] => 10262439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281276 [patent_doc_number] => 20040063653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol' [patent_app_type] => new [patent_app_number] => 10/168217 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24369 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063653.pdf [firstpage_image] =>[orig_patent_app_number] => 10168217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635403 [patent_doc_number] => 20030211614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Methods for increasing the efficiency of recombinant AAV product' [patent_app_type] => new [patent_app_number] => 10/261188 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12964 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211614.pdf [firstpage_image] =>[orig_patent_app_number] => 10261188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6767066 [patent_doc_number] => 20030101466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Method for screening for agents against cancer using an immunosuppression animal model' [patent_app_type] => new [patent_app_number] => 10/262089 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16390 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20030101466.pdf [firstpage_image] =>[orig_patent_app_number] => 10262089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 195952 [patent_doc_number] => 07635688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Development of a preventive vaccine for filovirus infection in primates' [patent_app_type] => utility [patent_app_number] => 10/491121 [patent_app_country] => US [patent_app_date] => 2002-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 15237 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635688.pdf [firstpage_image] =>[orig_patent_app_number] => 10491121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869470 [patent_doc_number] => 20030082159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Lentiviral vector-mediated gene transfer and uses thereof' [patent_app_type] => new [patent_app_number] => 10/245050 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 13612 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082159.pdf [firstpage_image] =>[orig_patent_app_number] => 10245050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861657 [patent_doc_number] => 20030092665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Methods and compositions for administering DNA to mucosal surfaces' [patent_app_type] => new [patent_app_number] => 10/243472 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13005 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092665.pdf [firstpage_image] =>[orig_patent_app_number] => 10243472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 52660 [patent_doc_number] => 07771931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Methods for diagnosing and treating diseases and conditions associated with protein kinase Cλ' [patent_app_type] => utility [patent_app_number] => 10/488292 [patent_app_country] => US [patent_app_date] => 2002-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17289 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/771/07771931.pdf [firstpage_image] =>[orig_patent_app_number] => 10488292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359535 [patent_doc_number] => 07485414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Modulators of angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/231956 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26528 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485414.pdf [firstpage_image] =>[orig_patent_app_number] => 10231956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869448 [patent_doc_number] => 20030082137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Interleukin-3 gene therapy for cancer' [patent_app_type] => new [patent_app_number] => 10/231735 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15927 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082137.pdf [firstpage_image] =>[orig_patent_app_number] => 10231735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 690833 [patent_doc_number] => 07074772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Design principle for the construction of expression constructs for gene therapy' [patent_app_type] => utility [patent_app_number] => 10/228811 [patent_app_country] => US [patent_app_date] => 2002-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11499 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074772.pdf [firstpage_image] =>[orig_patent_app_number] => 10228811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 397539 [patent_doc_number] => 07294508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-13 [patent_title] => 'Isolation of inner cell mass for the establishment of human embryonic stem cell (hESC) lines' [patent_app_type] => utility [patent_app_number] => 10/226711 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 5765 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/294/07294508.pdf [firstpage_image] =>[orig_patent_app_number] => 10226711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 397539 [patent_doc_number] => 07294508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-13 [patent_title] => 'Isolation of inner cell mass for the establishment of human embryonic stem cell (hESC) lines' [patent_app_type] => utility [patent_app_number] => 10/226711 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 5765 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/294/07294508.pdf [firstpage_image] =>[orig_patent_app_number] => 10226711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 687201 [patent_doc_number] => 07078506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-18 [patent_title] => 'Canineil-4nucleic acid molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/218654 [patent_app_country] => US [patent_app_date] => 2002-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47954 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078506.pdf [firstpage_image] =>[orig_patent_app_number] => 10218654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 917869 [patent_doc_number] => 07323618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => 'Tissue specific expression of exogenous proteins in transgenic chickens' [patent_app_type] => utility [patent_app_number] => 10/216098 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 14209 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323618.pdf [firstpage_image] =>[orig_patent_app_number] => 10216098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852029 [patent_doc_number] => 20030144232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Expression system' [patent_app_type] => new [patent_app_number] => 10/216054 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19168 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144232.pdf [firstpage_image] =>[orig_patent_app_number] => 10216054 [rel_patent_id] =>[rel_patent_doc_number] =>)